**Author details**

Yoichi Matsunaga1\*, Midori Suenaga1 , Hironobu Takahashi1 and Akiko Furuta2

\*Address all correspondence to: matsunaga@ph.bunri-u.ac.jp

1 Department of Medical Pharmacology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Nishihama, Yamashiro-cho, Tokushima, Japan

2 Department of Psychiatry, Juntendo University, School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

#### **References**


dihydroxyvitamin D3, and 1,25-dihydroxyvitamin D3. *J Clin Endocrinol Metab* 50: 773– 775; 1980.

[9] Tsoukas, C. D.; Provvedini, D. M.; Manolagas, S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. *Science* 224: 1438–1440; 1984.

**Author details**

Tokyo, Japan

**References**

Yoichi Matsunaga1\*, Midori Suenaga1

98 A Critical Evaluation of Vitamin D - Clinical Overview

*J Biol Chem* 97: 249–264; 1932.

*Sci USA* 90: 8668–8672; 1993.

D2. *Am J Clin Nutr* 68: 854–858; 1998.

\*Address all correspondence to: matsunaga@ph.bunri-u.ac.jp

University, Nishihama, Yamashiro-cho, Tokushima, Japan

, Hironobu Takahashi1

1 Department of Medical Pharmacology, Faculty of Pharmaceutical Sciences, Tokushima Bunri

2 Department of Psychiatry, Juntendo University, School of Medicine, Hongo, Bunkyo-ku,

[1] Hunt, R. D.; Garcia, F. G.; Hegsted, D. M.; Kaplinsky, N. Vitamin D2 and D3 in new world

[2] Steenbock, H.; Kletzien, S. W. F.; Haplin, J. G. The reaction of the chicken to irradiated ergosterol and irradiated yeast as contrasted with natural vitamin D of fish liver oils.

[3] Trang, H. M.; Cole, D. E.; Rubin, L. A.; Pierratos, A.; Sui, S.; Vieth, R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin

[4] Marx, S. J.; Jones, G.; Weinstein, R. S.; Chrousos, G. P.; Renquist, D. M. Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3

[5] Mawer, E. B.; Jones, G.; Davies, M.; Still, P. E.; Byford, V.; Schroeder, N. J.; Makin, H. L. J.; Bishop, C. W.; Knutson, J. C. Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2

[6] Holmberg, I.; Berlin, T.; Ewerth, S.; Bjorkhem, I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation

[7] Guo, Y. D.; Strugnell, S.; Back, D. W.; Jones, G. Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. *Proc Natl Acad*

[8] Jones, G.; Byrnes, B.; Palma, F.; Segev, D. Mazur, Y. Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24,25-

detectable in human serum. *J Clin Endocrinol Metab* 83: 2156–2166; 1998.

primates: influence on calcium absorption. *Science* 157: 943–945; 1967.

or only vitamin D2. *J Clin Endocrinol Metab* 69: 1282–1290; 1989.

of vitamin D2 and D3. *Scand J Clin Lab Invest* 46: 785–790; 1986.

and Akiko Furuta2


residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. *Proc Natl Acad Sci USA* 16: 10086–10091; 1997.

[36] Liu, H.; Farr-Jones, S.; Ulyanov, N. B.; Llinas, M.; Marqusee, S.; Groth, D.; Cohen, F. E.; Prusiner, S. B.; James, T. L. Solution structure of Syrian hamster prion protein rPrP(90– 231). *Biochemistry* 38: 5362–5377; 1999.

[22] Suzuki, N.; Cheung, T. T.; Cai, X. D.; Odaka, A.; Otvos, L. Jr; Eckman, C.; Golde, T. E.; Younkin, S. G. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants. *Science* 264: 1336–1340; 1994.

[23] Prior, R.; D'rso, D.; Frank, R.; Prikulis, I.; Cleven, S.; Ihl, R.; Pavlakovic, G. Selective binding of soluble Aβ1–40 and Aβ1–42 to a subset of senile plaques. *Am J Pathol* 48:

[24] Glenner, G. G.; Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. *Biochem Biophys Res*

[25] Goedart, M. Tau protein and the neurofibrillary pathology of Alzheimer's disease.

[26] Haass, C.; Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from

[27] Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. G. Common structure of soluble amyloid oligomers implies common mechanism of

[28] Kuo, Y. M.; Emmerling, M. R.; Vigo-Pelfrey, C.; Kasunic, T. C.; Kirkpatrick, J. B.; Murdoch, G. H.; Ball, M. J.; Roher, A. E. Water-soluble Aβ;N-40, N-42 oligomers in

[29] Collee, J. G.; Bradley, R.; Liberski, P. P. Variant CJD (vCJD) and bovine spongiform encepharopathy (BSE): 10 and 20 years on: part 2. *Foria Neuropathol* 44: 102–110; 2006.

[31] Prusiner, S. B.; Bolton, D. C.; Groth, D. F.; Bowmann, K. A.; Choran, S. P.; Makinley, M. P. Further purification and characterization of scrapie prion. *Biochemistry* 21: 6942–6950;

[32] McKinley, M. P.; Masiarz, F. R.; Prusiner, S. B. Reversible chemical modification of the

[33] Pan, K. M; Baldwin, M.; Nguyen, J.; Gasset, M.; Serban, A.; Groth, D.; Mehlhorn, I.; Hung, Z.; Fletterick, R. J.; Choen, F. E.; Prusiner, S. B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. *Proc Natl Acsd Sci*

[34] Rike, R.; Hornemann, S.; Wider, G.; Billeter, M.; Glockshuber, R.; Wuthrich, K. NMR structure of the mouse prion protein domain PrP(121–231). *Nature* 382: 180–182; 1996.

[35] James, T. L.; Liu, H.; Ulyanov, N. B.; Farr-Jones, S.; Zhang, H.; Donne, D. G.; Kaneko, K.; Groth, D.; Mehlhorn, I.; Prusiner, S. B.; Cohen, F. E. Solution structure of a 142-

the Alzheimer's amyloid beta-peptide. *Nat Mol Cell Biol* 8: 101–112; 2007.

normal and Alzheimer disease brains. *J Biol Chem* 271: 4077–4081; 1996.

[30] Prusiner, S. B. Prion diseases and crisis. *Science* 278: 245–251; 1997.

1749–1756; 1996.

1982.

*Commun* 120: 885–890; 1984.

100 A Critical Evaluation of Vitamin D - Clinical Overview

*Trends Neurosci* 16: 460–465; 1993.

pathogenesis. *Science* 18: 486–489; 2003.

scrapie agent. *Science* 214: 1259–1261; 1998.

*USA* 90: 10962–10966; 1993.


**Section 3**
